Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).
Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.
On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
While President-elect Donald Trump isn't new to the White House, most of his proposed Cabinet appointees are. The Cabinet ...
The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...
The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...
Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...
Aquestive Therapeutics' Anaphylm is nearing FDA approval, potentially disrupting the U.S. anaphylaxis market dominated by ...
Good Day, Turks and Caicos Islands, I welcome this opportunity to address you as we stand on the cusp of a New Year. It is a ...